Curis reported $806K in Interest Income for its fiscal quarter ending in September of 2023.





Interest Income Change Date
AstraZeneca USD 80M 7M Jun/2026
Bayer EUR 169M 39M Dec/2025
CSL USD 18M 1000K Dec/2024
Curis USD 806K 9K Sep/2023
Eli Lilly USD 65M 25M Sep/2025
Exelixis USD 16.13M 1.3M Mar/2026
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 38.12M 4.43M Jun/2026
Merck USD 35M 34M Mar/2026
Pfizer USD -0.04 115M Jun/2026
Sanofi EUR 77M 17M Jun/2026
Takeda JPY 24.61B 213.76B Jun/2026
Verastem USD 831K 1.04M Sep/2024